SENTI BIOSCIENCES, INC. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.29 USD | +4.05% |
|
-5.69% | -56.06% |
Chart calendar Senti Biosciences, Inc.
2c47b.5N_Hm-Fdlh9Smi8f3X7tG8Ey-91bNTcWqHiKIL4_iuE.lo6sz9Q44k0jr0BwuwmeaLlanaoTQnhvnT3fVIZ16YeTlLf4o2XgThmtdg~12b5bb30107027adc5a1128c72d98009
Upcoming events on Senti Biosciences, Inc.
Past events on Senti Biosciences, Inc.
| 22/03/2024 01:35 am | Q4 2023 Earnings Release |
| 09/12/2023 | American Society of Hematology Meeting |
| 14/11/2023 02:45 am | Q3 2023 Earnings Release |
| 04/11/2023 09:30 pm | Society for Immunotherapy of Cancer Meeting - Abstract number: 270 |
| 04/11/2023 09:30 pm | Society for Immunotherapy of Cancer Meeting - Abstract number: 430 |
| 04/11/2023 09:30 pm | Society for Immunotherapy of Cancer Meeting - Abstract number: 24 |
| 03/11/2023 09:30 pm | Society for Immunotherapy of Cancer Meeting - Abstract number: 257 |
| 12/10/2023 03:45 am | Cell & Gene Meeting on the Mesa Conference |
| 10/10/2023 08:15 pm | Cell & Gene Meeting on the Mesa Conference - Panel |
| 03/10/2023 11:00 pm | Chardan Genetic Medicines Conference |
| 26/09/2023 | Society for Natural Immunity Meeting |
| 14/09/2023 12:25 am | Morgan Stanley Global Healthcare Conference |
| 11/09/2023 04:30 pm | H.C. Wainwright Global Investment Conference |
| 11/08/2023 06:05 pm | Q2 2023 Earnings Release |
| 16/06/2023 08:30 pm | Annual General Meeting |
| 20/05/2023 08:45 pm | American Society of Gene Cell Therapy Meeting - Abstract No: 341 |
| 20/05/2023 12:30 am | American Society of Gene and Cell Therapy Meeting - Abstract No: 1535 |
| 20/05/2023 12:30 am | American Society of Gene and Cell Therapy Meeting - Abstract No: 1408 |
| 19/05/2023 03:30 am | American Society of Gene Cell Therapy Meeting - Abstract No: 150 |
| 16/05/2023 12:00 am | JMP Securities Life Sciences Conference |
Annual results
| Fiscal Period | December | 2021 | 2022 |
|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 | 4,29 5,33 -19.59% |
|
EBITDA Million USD | Released Forecast Spread | 0,00 | -69,2 -69,7 0.66% |
|
EBIT Million USD | Released Forecast Spread | 0,00 | -70,6 -71,0 0.58% |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 0,00 | -58,2 -59,3 1.82% |
|
Net income Million USD | Released Forecast Spread | -55,3 | -58,2 -60,3 3.4% |
|
EPS USD | Released Forecast Spread | -3,72 | -2,23 -1,92 -16.35% |
| Announcement Date | 01/04/22 | 22/03/23 |
Quarterly results
| Fiscal Period | December | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 |
|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 1,77 0,93 90.1% | 0,06 1,56 -96.21% | 1,29 0,70 83.71% | 0,94 0,75 24.93% | 0,34 0,70 -51.71% |
|
EBITDA Million USD | Released Forecast Spread | -19,6 -22,2 11.9% | ||||
|
EBIT Million USD | Released Forecast Spread | -17,1 -21,7 21.39% | -20,0 -20,1 0.44% | -19,8 -21,6 8.31% | -19,6 -21,8 10.06% | -18,2 -20,0 9.08% |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -18,2 -17,0 -7.12% | -18,7 -19,0 1.46% | -18,7 -20,0 6.52% | -36,6 -19,0 -92.71% | |
|
Net income Million USD | Released Forecast Spread | -16,6 -21,7 23.35% | -18,2 -19,6 7.11% | -18,7 -21,0 10.78% | -18,7 -21,2 11.74% | -36,6 -19,0 -92.71% |
|
EPS USD | Released Forecast Spread | -0,38 -0,50 24% | -0,42 -0,47 10% | -0,42 -0,48 11.58% | -0,42 -0,48 11.72% | -0,34 -0,44 23.08% |
| Announcement Date | 10/11/22 | 22/03/23 | 09/05/23 | 11/08/23 | 14/11/23 |
More events
Past sector events for Senti Biosciences, Inc.
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- SNTI Stock
- Calendar Senti Biosciences, Inc.
